| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.51e-09 | 188 | 45 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 6.78e-07 | 599 | 45 | 10 | GO:0050839 | |
| GeneOntologyMolecularFunction | integrin binding | 2.55e-06 | 175 | 45 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | calcium ion binding | CRELD2 SNED1 STAB2 PCDHGC5 MEGF6 MEGF8 TENM2 NOTCH3 NOTCH4 DLL3 | 5.03e-06 | 749 | 45 | 10 | GO:0005509 |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 1.49e-05 | 3 | 45 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | Notch binding | 3.01e-05 | 27 | 45 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | structural molecule activity | 7.55e-04 | 891 | 45 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 2.66e-03 | 34 | 45 | 2 | GO:0046625 | |
| GeneOntologyBiologicalProcess | axon guidance | 4.51e-10 | 285 | 45 | 10 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.67e-10 | 286 | 45 | 10 | GO:0097485 | |
| GeneOntologyBiologicalProcess | axonogenesis | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 TNR TENM2 WNT3A NOTCH3 | 2.63e-08 | 566 | 45 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 TNR TENM2 WNT3A NOTCH3 | 9.45e-08 | 642 | 45 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 TNR TENM2 WNT3A NOTCH3 | 4.36e-07 | 748 | 45 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 TNR TENM2 WNT3A NOTCH3 | 8.68e-07 | 802 | 45 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 TNR TENM2 WNT3A NOTCH3 | 1.07e-06 | 819 | 45 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 TNR TENM2 WNT3A NOTCH3 | 1.16e-06 | 826 | 45 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron development | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 CDNF LAMC2 TENM4 MEGF8 TNR TENM2 TNXB WNT3A NOTCH3 | 1.58e-06 | 1463 | 45 | 14 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | LAMA3 NTNG1 LAMB1 TENM4 PCDHGC5 TNR ITGB4 TENM2 TNXB MEGF11 WNT3A NOTCH4 | 2.24e-06 | 1077 | 45 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | neuron projection development | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 CDNF LAMC2 MEGF8 TNR TENM2 TNXB WNT3A NOTCH3 | 2.24e-06 | 1285 | 45 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 TNR TENM2 WNT3A NOTCH3 NOTCH4 | 6.48e-06 | 1194 | 45 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | LRP3 LAMB1 LAMB2 TENM4 MEGF8 TNXB WNT3A NOTCH4 DLL3 SP7 WIF1 | 2.52e-05 | 1141 | 45 | 11 | GO:0045597 |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 4.63e-05 | 5 | 45 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 6.40e-05 | 99 | 45 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 MEGF8 ITGB4 MEGF11 WNT3A SP7 | 6.67e-05 | 1269 | 45 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 6.94e-05 | 6 | 45 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 6.94e-05 | 6 | 45 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 8.35e-05 | 106 | 45 | 4 | GO:0051149 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 8.80e-05 | 338 | 45 | 6 | GO:0045165 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.53e-04 | 124 | 45 | 4 | GO:0007229 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.60e-04 | 377 | 45 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.62e-04 | 378 | 45 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.64e-04 | 379 | 45 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | cell fate determination | 1.77e-04 | 50 | 45 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | axon extension | 2.12e-04 | 135 | 45 | 4 | GO:0048675 | |
| GeneOntologyBiologicalProcess | cell junction organization | 2.15e-04 | 974 | 45 | 9 | GO:0034330 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.51e-04 | 410 | 45 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 2.53e-04 | 11 | 45 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.90e-04 | 59 | 45 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 3.03e-04 | 12 | 45 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 4.17e-04 | 14 | 45 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | cardiac cell fate commitment | 4.17e-04 | 14 | 45 | 2 | GO:0060911 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 6.20e-04 | 17 | 45 | 2 | GO:0048841 | |
| GeneOntologyBiologicalProcess | synapse organization | 6.53e-04 | 685 | 45 | 7 | GO:0050808 | |
| GeneOntologyBiologicalProcess | tRNA threonylcarbamoyladenosine metabolic process | 7.77e-04 | 19 | 45 | 2 | GO:0070525 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 7.92e-04 | 927 | 45 | 8 | GO:0030155 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 8.17e-04 | 84 | 45 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 9.19e-04 | 199 | 45 | 4 | GO:0051147 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 9.52e-04 | 21 | 45 | 2 | GO:2000047 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 1.05e-03 | 22 | 45 | 2 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 1.05e-03 | 22 | 45 | 2 | GO:1902284 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.06e-03 | 207 | 45 | 4 | GO:1990138 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.06e-03 | 92 | 45 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | STAB2 TENM4 NR4A1 ITGB4 MEGF11 WNT3A NOTCH3 NOTCH4 DLL3 NR0B1 | 1.12e-03 | 1483 | 45 | 10 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.14e-03 | 23 | 45 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | gastrulation | 1.16e-03 | 212 | 45 | 4 | GO:0007369 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm development | 1.25e-03 | 24 | 45 | 2 | GO:0048339 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 1.25e-03 | 372 | 45 | 5 | GO:0060485 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 1.52e-03 | 104 | 45 | 3 | GO:0030516 | |
| GeneOntologyBiologicalProcess | positive regulation of embryonic development | 1.58e-03 | 27 | 45 | 2 | GO:0040019 | |
| GeneOntologyBiologicalProcess | myelin assembly | 1.70e-03 | 28 | 45 | 2 | GO:0032288 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.73e-03 | 109 | 45 | 3 | GO:0034446 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 1.98e-03 | 1327 | 45 | 9 | GO:0040012 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 2.39e-03 | 122 | 45 | 3 | GO:0061387 | |
| GeneOntologyBiologicalProcess | segmentation | 2.45e-03 | 123 | 45 | 3 | GO:0035282 | |
| GeneOntologyBiologicalProcess | gliogenesis | 2.49e-03 | 435 | 45 | 5 | GO:0042063 | |
| GeneOntologyCellularComponent | laminin complex | 9.19e-12 | 10 | 45 | 5 | GO:0043256 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMA3 LAMA5 LAMB1 SNED1 LAMB2 LAMC2 FCGBP MEGF6 TNR SSPOP ITGB4 ADAMTSL4 TNXB | 7.37e-10 | 656 | 45 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMA3 LAMA5 LAMB1 SNED1 LAMB2 LAMC2 FCGBP MEGF6 TNR SSPOP ITGB4 ADAMTSL4 TNXB | 7.65e-10 | 658 | 45 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 MEGF6 TNR SSPOP ITGB4 ADAMTSL4 TNXB | 1.17e-08 | 530 | 45 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | laminin-5 complex | 3.72e-08 | 4 | 45 | 3 | GO:0005610 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.37e-08 | 17 | 45 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.69e-07 | 59 | 45 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | basement membrane | 2.36e-07 | 122 | 45 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin-2 complex | 4.53e-06 | 2 | 45 | 2 | GO:0005607 | |
| GeneOntologyCellularComponent | laminin-10 complex | 1.36e-05 | 3 | 45 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 1.36e-05 | 3 | 45 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 1.36e-05 | 3 | 45 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | laminin-3 complex | 1.36e-05 | 3 | 45 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | tenascin complex | 2.71e-05 | 4 | 45 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | EKC/KEOPS complex | 9.45e-05 | 7 | 45 | 2 | GO:0000408 | |
| GeneOntologyCellularComponent | hemidesmosome | 2.46e-04 | 11 | 45 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 3.48e-04 | 13 | 45 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | cell surface | 5.13e-04 | 1111 | 45 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.69e-03 | 817 | 45 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.29e-03 | 33 | 45 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.58e-03 | 332 | 45 | 4 | GO:0005788 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 1.79e-06 | 7 | 20 | 3 | HP:0020117 | |
| HumanPheno | Congenital localized absence of skin | 4.28e-06 | 9 | 20 | 3 | HP:0007383 | |
| HumanPheno | Mitten deformity | 4.28e-06 | 9 | 20 | 3 | HP:0004057 | |
| HumanPheno | Abnormal dermatological laboratory findings | 6.11e-06 | 10 | 20 | 3 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 6.11e-06 | 10 | 20 | 3 | HP:0003341 | |
| HumanPheno | Atypical scarring of skin | 7.38e-06 | 74 | 20 | 5 | HP:0000987 | |
| HumanPheno | Subepidermal blistering | 8.37e-06 | 11 | 20 | 3 | HP:0033804 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 8.37e-06 | 11 | 20 | 3 | HP:0032449 | |
| HumanPheno | Atrophic scars | 1.05e-05 | 37 | 20 | 4 | HP:0001075 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 1.11e-05 | 12 | 20 | 3 | HP:0031538 | |
| HumanPheno | Blistering by histological location | 1.44e-05 | 13 | 20 | 3 | HP:0033801 | |
| HumanPheno | Oral mucosal blisters | 1.83e-05 | 14 | 20 | 3 | HP:0200097 | |
| HumanPheno | Aplasia/Hypoplasia of the bladder | 2.81e-05 | 16 | 20 | 3 | HP:0010476 | |
| HumanPheno | Scarring alopecia of scalp | 2.81e-05 | 16 | 20 | 3 | HP:0004552 | |
| HumanPheno | Urethral stricture | 3.40e-05 | 17 | 20 | 3 | HP:0012227 | |
| HumanPheno | Milia | 3.40e-05 | 17 | 20 | 3 | HP:0001056 | |
| HumanPheno | Scarring | 3.56e-05 | 102 | 20 | 5 | HP:0100699 | |
| HumanPheno | Duplicated collecting system | 9.94e-05 | 24 | 20 | 3 | HP:0000081 | |
| HumanPheno | Abdominal organ duplication | 1.27e-04 | 69 | 20 | 4 | HP:0005217 | |
| HumanPheno | Renal duplication | 1.27e-04 | 69 | 20 | 4 | HP:0000075 | |
| HumanPheno | Blistering by anatomical location | 1.27e-04 | 26 | 20 | 3 | HP:0033800 | |
| HumanPheno | Renal tubular epithelial necrosis | 1.45e-04 | 5 | 20 | 2 | HP:0008682 | |
| HumanPheno | Renal necrosis | 1.45e-04 | 5 | 20 | 2 | HP:0032618 | |
| HumanPheno | Pyoderma | 1.45e-04 | 5 | 20 | 2 | HP:0000999 | |
| HumanPheno | Skin erosion | 1.59e-04 | 28 | 20 | 3 | HP:0200041 | |
| HumanPheno | Ureterocele | 1.77e-04 | 29 | 20 | 3 | HP:0000070 | |
| HumanPheno | Abnormal renal collecting system morphology | 1.96e-04 | 30 | 20 | 3 | HP:0004742 | |
| HumanPheno | Urinary bladder inflammation | 2.95e-04 | 159 | 20 | 5 | HP:0100577 | |
| HumanPheno | Urinary tract infections | 2.95e-04 | 159 | 20 | 5 | HP:0000094 | |
| HumanPheno | Fragile skin | 3.69e-04 | 37 | 20 | 3 | HP:0001030 | |
| HumanPheno | Aplasia cutis congenita | 5.02e-04 | 41 | 20 | 3 | HP:0001057 | |
| HumanPheno | Alopecia of scalp | 6.61e-04 | 45 | 20 | 3 | HP:0002293 | |
| HumanPheno | Dermal atrophy | 6.88e-04 | 107 | 20 | 4 | HP:0004334 | |
| HumanPheno | Abnormal bladder morphology | 8.69e-04 | 201 | 20 | 5 | HP:0025487 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 4.01e-06 | 12 | 38 | 3 | MP:0011159 | |
| MousePheno | blistering | 3.61e-05 | 24 | 38 | 3 | MP:0001208 | |
| Domain | EGF_1 | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 ADAM33 LAMC2 STAB2 TENM4 MEGF6 MEGF8 TNR SSPOP ITGB4 TENM2 TNXB MEGF11 NOTCH3 NOTCH4 DLL3 WIF1 | 7.35e-32 | 255 | 44 | 23 | PS00022 |
| Domain | EGF_2 | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 ADAM33 LAMC2 STAB2 TENM4 MEGF6 MEGF8 TNR SSPOP ITGB4 TENM2 TNXB MEGF11 NOTCH3 NOTCH4 DLL3 WIF1 | 1.83e-31 | 265 | 44 | 23 | PS01186 |
| Domain | EGF | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 ADAM33 LAMC2 STAB2 FCGBP TENM4 MEGF6 MEGF8 TNR TENM2 TNXB MEGF11 NOTCH3 NOTCH4 DLL3 WIF1 | 9.50e-31 | 235 | 44 | 22 | SM00181 |
| Domain | EGF-like_dom | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 ADAM33 LAMC2 STAB2 FCGBP TENM4 MEGF6 MEGF8 TNR TENM2 TNXB MEGF11 NOTCH3 NOTCH4 DLL3 WIF1 | 3.54e-30 | 249 | 44 | 22 | IPR000742 |
| Domain | EGF-like_CS | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 ADAM33 LAMC2 STAB2 TENM4 MEGF6 MEGF8 TNR ITGB4 TENM2 TNXB MEGF11 NOTCH3 NOTCH4 DLL3 WIF1 | 1.03e-29 | 261 | 44 | 22 | IPR013032 |
| Domain | EGF_3 | NTNG1 CRELD2 SNED1 ADAM33 STAB2 TENM4 MEGF6 MEGF8 TNR SSPOP TENM2 TNXB MEGF11 NOTCH3 NOTCH4 DLL3 WIF1 | 1.41e-21 | 235 | 44 | 17 | PS50026 |
| Domain | Laminin_EGF | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 LAMB2 LAMC2 STAB2 MEGF6 MEGF8 MEGF11 | 3.67e-21 | 38 | 44 | 11 | IPR002049 |
| Domain | EGF_Lam | LAMA3 NTNG1 LAMA5 LAMB1 LAMB2 LAMC2 STAB2 MEGF6 MEGF8 MEGF11 | 3.08e-19 | 35 | 44 | 10 | SM00180 |
| Domain | EGF_extracell | ADAM33 STAB2 TENM4 MEGF6 TNR ITGB4 TNXB MEGF11 NOTCH3 DLL3 WIF1 | 1.01e-18 | 60 | 44 | 11 | IPR013111 |
| Domain | EGF_2 | ADAM33 STAB2 TENM4 MEGF6 TNR ITGB4 TNXB MEGF11 NOTCH3 DLL3 WIF1 | 1.01e-18 | 60 | 44 | 11 | PF07974 |
| Domain | Growth_fac_rcpt_ | LAMA3 CRELD2 LAMA5 LAMB1 LAMB2 LAMC2 STAB2 MEGF6 MEGF8 TNXB NOTCH3 NOTCH4 DLL3 | 2.41e-17 | 156 | 44 | 13 | IPR009030 |
| Domain | Laminin_EGF | 6.30e-17 | 35 | 44 | 9 | PF00053 | |
| Domain | EGF_LAM_2 | 2.72e-15 | 30 | 44 | 8 | PS50027 | |
| Domain | EGF_LAM_1 | 2.72e-15 | 30 | 44 | 8 | PS01248 | |
| Domain | hEGF | 2.78e-13 | 28 | 44 | 7 | PF12661 | |
| Domain | EGF_CA | 9.39e-12 | 122 | 44 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.09e-11 | 124 | 44 | 9 | IPR001881 | |
| Domain | Laminin_N | 2.46e-10 | 16 | 44 | 5 | IPR008211 | |
| Domain | LAMININ_NTER | 2.46e-10 | 16 | 44 | 5 | PS51117 | |
| Domain | Laminin_N | 2.46e-10 | 16 | 44 | 5 | PF00055 | |
| Domain | LamNT | 2.46e-10 | 16 | 44 | 5 | SM00136 | |
| Domain | EGF | 4.96e-10 | 126 | 44 | 8 | PF00008 | |
| Domain | EGF_Ca-bd_CS | 1.01e-07 | 97 | 44 | 6 | IPR018097 | |
| Domain | EGF_CA | 1.14e-07 | 99 | 44 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.21e-07 | 100 | 44 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.72e-07 | 106 | 44 | 6 | IPR000152 | |
| Domain | LAMININ_IVA | 6.78e-07 | 8 | 44 | 3 | PS51115 | |
| Domain | Laminin_B | 6.78e-07 | 8 | 44 | 3 | PF00052 | |
| Domain | LamB | 6.78e-07 | 8 | 44 | 3 | SM00281 | |
| Domain | Laminin_IV | 6.78e-07 | 8 | 44 | 3 | IPR000034 | |
| Domain | EGF_CA | 1.74e-06 | 86 | 44 | 5 | PF07645 | |
| Domain | Galactose-bd-like | 2.70e-06 | 94 | 44 | 5 | IPR008979 | |
| Domain | EMI | 8.11e-06 | 17 | 44 | 3 | PS51041 | |
| Domain | Rhs_assc_core | 1.62e-05 | 3 | 44 | 2 | IPR022385 | |
| Domain | LAMININ_IVB | 1.62e-05 | 3 | 44 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 1.62e-05 | 3 | 44 | 2 | IPR013015 | |
| Domain | Tox-GHH_dom | 3.24e-05 | 4 | 44 | 2 | IPR028916 | |
| Domain | Notch | 3.24e-05 | 4 | 44 | 2 | IPR008297 | |
| Domain | Ten_N | 3.24e-05 | 4 | 44 | 2 | IPR009471 | |
| Domain | NODP | 3.24e-05 | 4 | 44 | 2 | PF07684 | |
| Domain | Ten_N | 3.24e-05 | 4 | 44 | 2 | PF06484 | |
| Domain | Notch_NODP_dom | 3.24e-05 | 4 | 44 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 3.24e-05 | 4 | 44 | 2 | IPR010660 | |
| Domain | TENEURIN_N | 3.24e-05 | 4 | 44 | 2 | PS51361 | |
| Domain | NOD | 3.24e-05 | 4 | 44 | 2 | PF06816 | |
| Domain | Tox-GHH | 3.24e-05 | 4 | 44 | 2 | PF15636 | |
| Domain | NOD | 3.24e-05 | 4 | 44 | 2 | SM01338 | |
| Domain | NODP | 3.24e-05 | 4 | 44 | 2 | SM01339 | |
| Domain | Laminin_aI | 5.40e-05 | 5 | 44 | 2 | IPR009254 | |
| Domain | Laminin_I | 5.40e-05 | 5 | 44 | 2 | PF06008 | |
| Domain | Laminin_II | 5.40e-05 | 5 | 44 | 2 | PF06009 | |
| Domain | Laminin_domII | 5.40e-05 | 5 | 44 | 2 | IPR010307 | |
| Domain | LNR | 5.40e-05 | 5 | 44 | 2 | PS50258 | |
| Domain | YD | 5.40e-05 | 5 | 44 | 2 | IPR006530 | |
| Domain | Notch_dom | 1.13e-04 | 7 | 44 | 2 | IPR000800 | |
| Domain | Notch | 1.13e-04 | 7 | 44 | 2 | PF00066 | |
| Domain | NL | 1.13e-04 | 7 | 44 | 2 | SM00004 | |
| Domain | VWF_dom | 1.31e-04 | 42 | 44 | 3 | IPR001007 | |
| Domain | PSI | 1.51e-04 | 44 | 44 | 3 | IPR016201 | |
| Domain | Ldl_recept_a | 1.62e-04 | 45 | 44 | 3 | PF00057 | |
| Domain | PSI | 1.73e-04 | 46 | 44 | 3 | SM00423 | |
| Domain | - | 1.73e-04 | 46 | 44 | 3 | 4.10.400.10 | |
| Domain | Integin_beta_N | 1.93e-04 | 9 | 44 | 2 | IPR033760 | |
| Domain | PSI_integrin | 1.93e-04 | 9 | 44 | 2 | PF17205 | |
| Domain | LDLRA_1 | 1.96e-04 | 48 | 44 | 3 | PS01209 | |
| Domain | LDLRA_2 | 2.08e-04 | 49 | 44 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 2.08e-04 | 49 | 44 | 3 | IPR002172 | |
| Domain | LDLa | 2.08e-04 | 49 | 44 | 3 | SM00192 | |
| Domain | Fol_N | 2.94e-04 | 11 | 44 | 2 | IPR003645 | |
| Domain | FOLN | 2.94e-04 | 11 | 44 | 2 | SM00274 | |
| Domain | EGF_3 | 3.53e-04 | 12 | 44 | 2 | PF12947 | |
| Domain | TIL | 3.53e-04 | 12 | 44 | 2 | PF01826 | |
| Domain | EGF_dom | 3.53e-04 | 12 | 44 | 2 | IPR024731 | |
| Domain | C8 | 3.53e-04 | 12 | 44 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 4.16e-04 | 13 | 44 | 2 | IPR014853 | |
| Domain | C8 | 4.16e-04 | 13 | 44 | 2 | SM00832 | |
| Domain | NHL | 4.16e-04 | 13 | 44 | 2 | PS51125 | |
| Domain | TIL_dom | 4.85e-04 | 14 | 44 | 2 | IPR002919 | |
| Domain | fn3 | 5.65e-04 | 162 | 44 | 4 | PF00041 | |
| Domain | VWD | 6.37e-04 | 16 | 44 | 2 | SM00216 | |
| Domain | EMI_domain | 6.37e-04 | 16 | 44 | 2 | IPR011489 | |
| Domain | VWF_type-D | 6.37e-04 | 16 | 44 | 2 | IPR001846 | |
| Domain | VWFD | 6.37e-04 | 16 | 44 | 2 | PS51233 | |
| Domain | VWD | 6.37e-04 | 16 | 44 | 2 | PF00094 | |
| Domain | CarboxyPept-like_regulatory | 7.21e-04 | 17 | 44 | 2 | IPR008969 | |
| Domain | VWC_out | 9.04e-04 | 19 | 44 | 2 | SM00215 | |
| Domain | FN3 | 9.28e-04 | 185 | 44 | 4 | SM00060 | |
| Domain | FN3 | 1.22e-03 | 199 | 44 | 4 | PS50853 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.45e-03 | 24 | 44 | 2 | IPR014715 | |
| Domain | - | 1.45e-03 | 24 | 44 | 2 | 4.10.530.10 | |
| Domain | FN3_dom | 1.46e-03 | 209 | 44 | 4 | IPR003961 | |
| Domain | Fibrinogen_C | 1.83e-03 | 27 | 44 | 2 | PF00147 | |
| Domain | FBG | 2.11e-03 | 29 | 44 | 2 | SM00186 | |
| Domain | - | 2.26e-03 | 30 | 44 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 2.26e-03 | 30 | 44 | 2 | IPR014716 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 3.10e-14 | 11 | 31 | 6 | M158 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 6.06e-12 | 46 | 31 | 7 | M239 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.98e-12 | 84 | 31 | 8 | M7098 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.87e-11 | 30 | 31 | 6 | M27216 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 7.19e-11 | 33 | 31 | 6 | M39503 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 8.56e-11 | 66 | 31 | 7 | MM15925 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.81e-09 | 59 | 31 | 6 | M27218 | |
| Pathway | WP_FOCAL_ADHESION | 5.02e-09 | 187 | 31 | 8 | MM15913 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.03e-09 | 30 | 31 | 5 | M27772 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.18e-09 | 199 | 31 | 8 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 8.18e-09 | 199 | 31 | 8 | M39402 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.33e-08 | 76 | 31 | 6 | M27219 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.60e-08 | 41 | 31 | 5 | M27778 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.98e-07 | 300 | 31 | 8 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.08e-07 | 302 | 31 | 8 | M39719 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.98e-07 | 66 | 31 | 5 | M18 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.72e-07 | 326 | 31 | 8 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.01e-07 | 339 | 31 | 8 | M39736 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.04e-07 | 30 | 31 | 4 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.04e-07 | 30 | 31 | 4 | M39641 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.37e-07 | 79 | 31 | 5 | M27643 | |
| Pathway | WP_CANCER_PATHWAYS | 9.32e-07 | 507 | 31 | 9 | M48302 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.00e-06 | 84 | 31 | 5 | M3228 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.57e-06 | 11 | 31 | 3 | M27372 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.95e-06 | 96 | 31 | 5 | M39834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.71e-06 | 13 | 31 | 3 | M47423 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 3.49e-06 | 439 | 31 | 8 | M42563 | |
| Pathway | PID_NOTCH_PATHWAY | 8.00e-06 | 59 | 31 | 4 | M17 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.41e-05 | 68 | 31 | 4 | M27303 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.72e-05 | 27 | 31 | 3 | M39545 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 4.66e-05 | 5 | 31 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.66e-05 | 5 | 31 | 2 | MM14733 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 5.50e-05 | 34 | 31 | 3 | M39390 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 5.75e-05 | 97 | 31 | 4 | MM15926 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 6.49e-05 | 325 | 31 | 6 | M12868 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 6.73e-05 | 101 | 31 | 4 | M39448 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 6.98e-05 | 6 | 31 | 2 | M27068 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 9.76e-05 | 7 | 31 | 2 | MM14734 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.19e-04 | 117 | 31 | 4 | M19248 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.23e-04 | 118 | 31 | 4 | M39852 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.28e-04 | 45 | 31 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.37e-04 | 46 | 31 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.46e-04 | 47 | 31 | 3 | M7946 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.67e-04 | 9 | 31 | 2 | MM15117 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.96e-04 | 250 | 31 | 5 | M27554 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.38e-04 | 140 | 31 | 4 | M587 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.54e-04 | 11 | 31 | 2 | M47865 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.58e-04 | 143 | 31 | 4 | M27275 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.05e-04 | 12 | 31 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 3.05e-04 | 12 | 31 | 2 | M47533 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.18e-04 | 61 | 31 | 3 | M39540 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.18e-04 | 61 | 31 | 3 | M27103 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 3.43e-04 | 154 | 31 | 4 | M39739 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 3.51e-04 | 155 | 31 | 4 | M522 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 3.60e-04 | 13 | 31 | 2 | M47534 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.05e-04 | 161 | 31 | 4 | M39770 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.83e-04 | 15 | 31 | 2 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.83e-04 | 15 | 31 | 2 | MM14922 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 4.83e-04 | 15 | 31 | 2 | M27273 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.18e-04 | 72 | 31 | 3 | M39403 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 5.40e-04 | 73 | 31 | 3 | MM15126 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.40e-04 | 73 | 31 | 3 | MM15906 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 5.51e-04 | 16 | 31 | 2 | M47424 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 7.01e-04 | 18 | 31 | 2 | M31 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 7.01e-04 | 18 | 31 | 2 | M614 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 9.24e-04 | 532 | 31 | 6 | M27870 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 9.94e-04 | 90 | 31 | 3 | M631 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.15e-03 | 23 | 31 | 2 | MM14954 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.20e-03 | 96 | 31 | 3 | MM14592 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.25e-03 | 24 | 31 | 2 | M11190 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 1.68e-03 | 108 | 31 | 3 | M48078 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.71e-03 | 28 | 31 | 2 | M6177 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 1.71e-03 | 28 | 31 | 2 | M47835 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 1.71e-03 | 28 | 31 | 2 | M77 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.34e-03 | 258 | 31 | 4 | MM14572 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 2.97e-03 | 37 | 31 | 2 | M39506 | |
| Pathway | PID_FRA_PATHWAY | 2.97e-03 | 37 | 31 | 2 | M65 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.13e-03 | 38 | 31 | 2 | MM15865 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.13e-03 | 38 | 31 | 2 | M39657 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-03 | 39 | 31 | 2 | M27417 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.30e-03 | 39 | 31 | 2 | MM14604 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-03 | 39 | 31 | 2 | MM15165 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 4.00e-03 | 43 | 31 | 2 | M39565 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 4.37e-03 | 45 | 31 | 2 | M39864 | |
| Pathway | PID_PS1_PATHWAY | 4.56e-03 | 46 | 31 | 2 | M70 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.76e-03 | 47 | 31 | 2 | MM14925 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 4.96e-03 | 48 | 31 | 2 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 6.01e-03 | 53 | 31 | 2 | M8276 | |
| Pathway | PID_TAP63_PATHWAY | 6.24e-03 | 54 | 31 | 2 | M256 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 9.20e-03 | 66 | 31 | 2 | M101 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.00e-02 | 69 | 31 | 2 | M46439 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.15e-02 | 74 | 31 | 2 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.15e-02 | 74 | 31 | 2 | M16376 | |
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 1.81e-13 | 8 | 46 | 5 | 23529140 | |
| Pubmed | 8.11e-13 | 10 | 46 | 5 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.49e-12 | 11 | 46 | 5 | 21524702 | |
| Pubmed | 2.54e-12 | 12 | 46 | 5 | 9396756 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 9.62e-12 | 15 | 46 | 5 | 15895400 | |
| Pubmed | 1.40e-11 | 16 | 46 | 5 | 17601529 | ||
| Pubmed | 2.74e-11 | 18 | 46 | 5 | 11311202 | ||
| Pubmed | 4.01e-11 | 6 | 46 | 4 | 10671376 | ||
| Pubmed | 4.94e-11 | 20 | 46 | 5 | 22911573 | ||
| Pubmed | 7.75e-11 | 175 | 46 | 8 | 28071719 | ||
| Pubmed | 9.34e-11 | 7 | 46 | 4 | 7921537 | ||
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 1.87e-10 | 8 | 46 | 4 | 9489770 | |
| Pubmed | 1.87e-10 | 8 | 46 | 4 | 8872465 | ||
| Pubmed | 2.08e-10 | 26 | 46 | 5 | 24742657 | ||
| Pubmed | 3.75e-10 | 29 | 46 | 5 | 22613833 | ||
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 8.78e-10 | 11 | 46 | 4 | 8707838 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 8.78e-10 | 11 | 46 | 4 | 23472759 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 9.86e-10 | 79 | 46 | 6 | 18757743 | |
| Pubmed | 1.90e-09 | 13 | 46 | 4 | 9670011 | ||
| Pubmed | 2.06e-09 | 40 | 46 | 5 | 27068110 | ||
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 2.17e-09 | 3 | 46 | 3 | 15316072 | |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 3.62e-09 | 15 | 46 | 4 | 12921739 | |
| Pubmed | 3.62e-09 | 15 | 46 | 4 | 9264260 | ||
| Pubmed | 8.65e-09 | 4 | 46 | 3 | 10651091 | ||
| Pubmed | 8.65e-09 | 4 | 46 | 3 | 22673183 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 8.65e-09 | 4 | 46 | 3 | 35008625 | |
| Pubmed | 8.65e-09 | 4 | 46 | 3 | 10801807 | ||
| Pubmed | 8.65e-09 | 4 | 46 | 3 | 8081888 | ||
| Pubmed | 1.58e-08 | 21 | 46 | 4 | 27856617 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 10964500 | ||
| Pubmed | IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. | 2.16e-08 | 5 | 46 | 3 | 9271670 | |
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 9719032 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 12743034 | ||
| Pubmed | Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. | 2.16e-08 | 5 | 46 | 3 | 16581764 | |
| Pubmed | Laminin 5 regulates polycystic kidney cell proliferation and cyst formation. | 2.16e-08 | 5 | 46 | 3 | 16870608 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 3.92e-08 | 26 | 46 | 4 | 34189436 | |
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 4.32e-08 | 6 | 46 | 3 | 9506922 | |
| Pubmed | 4.32e-08 | 6 | 46 | 3 | 20301304 | ||
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 4.32e-08 | 6 | 46 | 3 | 16236823 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 4.43e-08 | 560 | 46 | 9 | 21653829 | |
| Pubmed | 5.32e-08 | 153 | 46 | 6 | 25037231 | ||
| Pubmed | 7.55e-08 | 7 | 46 | 3 | 11891225 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 7.55e-08 | 7 | 46 | 3 | 9004048 | |
| Pubmed | 7.55e-08 | 7 | 46 | 3 | 14557481 | ||
| Pubmed | 7.69e-08 | 81 | 46 | 5 | 39217171 | ||
| Pubmed | 8.04e-08 | 164 | 46 | 6 | 32409323 | ||
| Pubmed | 8.90e-08 | 608 | 46 | 9 | 16713569 | ||
| Pubmed | 1.81e-07 | 9 | 46 | 3 | 11118901 | ||
| Pubmed | 1.81e-07 | 9 | 46 | 3 | 16245338 | ||
| Pubmed | 1.81e-07 | 9 | 46 | 3 | 12482924 | ||
| Pubmed | 2.22e-07 | 100 | 46 | 5 | 24859004 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.58e-07 | 10 | 46 | 3 | 23665443 | |
| Pubmed | 2.58e-07 | 10 | 46 | 3 | 11784026 | ||
| Pubmed | 3.46e-07 | 210 | 46 | 6 | 16537572 | ||
| Pubmed | Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. | 3.55e-07 | 11 | 46 | 3 | 11435469 | |
| Pubmed | 3.55e-07 | 11 | 46 | 3 | 10878608 | ||
| Pubmed | 3.55e-07 | 11 | 46 | 3 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 3.55e-07 | 11 | 46 | 3 | 16757171 | |
| Pubmed | 4.72e-07 | 12 | 46 | 3 | 26794322 | ||
| Pubmed | 4.72e-07 | 12 | 46 | 3 | 15465494 | ||
| Pubmed | 5.06e-07 | 118 | 46 | 5 | 21078624 | ||
| Pubmed | 6.14e-07 | 13 | 46 | 3 | 12682087 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 6.14e-07 | 13 | 46 | 3 | 11578869 | |
| Pubmed | 6.14e-07 | 13 | 46 | 3 | 36350252 | ||
| Pubmed | 7.80e-07 | 14 | 46 | 3 | 14757642 | ||
| Pubmed | 9.74e-07 | 15 | 46 | 3 | 12971992 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.87e-07 | 135 | 46 | 5 | 28675934 | |
| Pubmed | 1.12e-06 | 257 | 46 | 6 | 16335952 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.20e-06 | 16 | 46 | 3 | 12617809 | |
| Pubmed | 1.20e-06 | 16 | 46 | 3 | 23153495 | ||
| Pubmed | Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. | 1.20e-06 | 16 | 46 | 3 | 11739954 | |
| Pubmed | 1.20e-06 | 16 | 46 | 3 | 30579834 | ||
| Pubmed | 1.45e-06 | 146 | 46 | 5 | 27068509 | ||
| Pubmed | 1.45e-06 | 17 | 46 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.45e-06 | 17 | 46 | 3 | 15821257 | |
| Pubmed | 1.45e-06 | 17 | 46 | 3 | 39315665 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 1.45e-06 | 17 | 46 | 3 | 15056720 | |
| Pubmed | 1.61e-06 | 64 | 46 | 4 | 22261194 | ||
| Pubmed | Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. | 1.71e-06 | 2 | 46 | 2 | 21743455 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 9010770 | ||
| Pubmed | Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. | 1.71e-06 | 2 | 46 | 2 | 33665264 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25572698 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 12382139 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 10399963 | ||
| Pubmed | Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. | 1.71e-06 | 2 | 46 | 2 | 17696940 | |
| Pubmed | The junctional epithelium originates from the odontogenic epithelium of an erupted tooth. | 1.71e-06 | 2 | 46 | 2 | 24785116 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25326539 | ||
| Pubmed | Biological function of laminin-5 and pathogenic impact of its deficiency. | 1.71e-06 | 2 | 46 | 2 | 17000025 | |
| Pubmed | The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. | 1.71e-06 | 2 | 46 | 2 | 19147489 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25658374 | ||
| Pubmed | Association study between the TNXB locus and schizophrenia in a Japanese population. | 1.71e-06 | 2 | 46 | 2 | 17192952 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11810295 | ||
| Pubmed | A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. | 1.71e-06 | 2 | 46 | 2 | 11777956 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29599141 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 21876163 | ||
| Pubmed | 1.74e-06 | 18 | 46 | 3 | 14730302 | ||
| Pubmed | 1.74e-06 | 18 | 46 | 3 | 15689374 | ||
| Pubmed | 2.81e-06 | 167 | 46 | 5 | 22159717 | ||
| Pubmed | 2.83e-06 | 21 | 46 | 3 | 21408207 | ||
| Pubmed | 2.83e-06 | 21 | 46 | 3 | 28656980 | ||
| Interaction | HOXA1 interactions | 7.66e-08 | 356 | 45 | 9 | int:HOXA1 | |
| Interaction | FBXO2 interactions | 2.59e-07 | 411 | 45 | 9 | int:FBXO2 | |
| Interaction | SDF2L1 interactions | 5.02e-07 | 322 | 45 | 8 | int:SDF2L1 | |
| Interaction | IGFL3 interactions | 6.78e-07 | 75 | 45 | 5 | int:IGFL3 | |
| Interaction | SLURP1 interactions | 7.76e-07 | 144 | 45 | 6 | int:SLURP1 | |
| Interaction | SIRPD interactions | 1.34e-06 | 86 | 45 | 5 | int:SIRPD | |
| Interaction | DEFA1 interactions | 2.84e-06 | 100 | 45 | 5 | int:DEFA1 | |
| Interaction | PRG2 interactions | 3.01e-06 | 285 | 45 | 7 | int:PRG2 | |
| Interaction | IGSF5 interactions | 3.72e-06 | 14 | 45 | 3 | int:IGSF5 | |
| Interaction | ATXN7 interactions | 4.34e-06 | 109 | 45 | 5 | int:ATXN7 | |
| Interaction | MFAP5 interactions | 5.43e-06 | 52 | 45 | 4 | int:MFAP5 | |
| Interaction | ITGB4 interactions | 8.48e-06 | 125 | 45 | 5 | int:ITGB4 | |
| Interaction | CFC1 interactions | 8.82e-06 | 126 | 45 | 5 | int:CFC1 | |
| Interaction | MANEA interactions | 9.65e-06 | 60 | 45 | 4 | int:MANEA | |
| Interaction | GGH interactions | 1.59e-05 | 243 | 45 | 6 | int:GGH | |
| Interaction | EGFL7 interactions | 2.61e-05 | 77 | 45 | 4 | int:EGFL7 | |
| Interaction | NID2 interactions | 4.03e-05 | 86 | 45 | 4 | int:NID2 | |
| Interaction | PTPRK interactions | 4.54e-05 | 177 | 45 | 5 | int:PTPRK | |
| Interaction | ELSPBP1 interactions | 5.25e-05 | 92 | 45 | 4 | int:ELSPBP1 | |
| Interaction | ATN1 interactions | 5.90e-05 | 187 | 45 | 5 | int:ATN1 | |
| Interaction | TSHR interactions | 6.20e-05 | 96 | 45 | 4 | int:TSHR | |
| Interaction | BCAN interactions | 7.05e-05 | 36 | 45 | 3 | int:BCAN | |
| Interaction | ST14 interactions | 9.53e-05 | 207 | 45 | 5 | int:ST14 | |
| Interaction | EDN3 interactions | 9.81e-05 | 108 | 45 | 4 | int:EDN3 | |
| Interaction | LAMA5 interactions | 1.34e-04 | 117 | 45 | 4 | int:LAMA5 | |
| Interaction | DLX4 interactions | 1.35e-04 | 8 | 45 | 2 | int:DLX4 | |
| Interaction | DNASE1L1 interactions | 1.48e-04 | 120 | 45 | 4 | int:DNASE1L1 | |
| Interaction | ALPP interactions | 1.62e-04 | 123 | 45 | 4 | int:ALPP | |
| Interaction | CACNA1A interactions | 1.62e-04 | 123 | 45 | 4 | int:CACNA1A | |
| Interaction | FBXO6 interactions | 1.66e-04 | 717 | 45 | 8 | int:FBXO6 | |
| Interaction | LAMC1 interactions | 2.32e-04 | 135 | 45 | 4 | int:LAMC1 | |
| Interaction | GML interactions | 2.95e-04 | 58 | 45 | 3 | int:GML | |
| Interaction | BTNL2 interactions | 3.92e-04 | 155 | 45 | 4 | int:BTNL2 | |
| Interaction | ITGA6 interactions | 4.02e-04 | 156 | 45 | 4 | int:ITGA6 | |
| Interaction | GGT6 interactions | 4.36e-04 | 14 | 45 | 2 | int:GGT6 | |
| Interaction | ABCG8 interactions | 5.03e-04 | 15 | 45 | 2 | int:ABCG8 | |
| Interaction | C1orf54 interactions | 5.20e-04 | 167 | 45 | 4 | int:C1orf54 | |
| Interaction | FIBIN interactions | 5.35e-04 | 71 | 45 | 3 | int:FIBIN | |
| Interaction | WNT1 interactions | 5.74e-04 | 16 | 45 | 2 | int:WNT1 | |
| Interaction | MAML1 interactions | 5.80e-04 | 73 | 45 | 3 | int:MAML1 | |
| Interaction | PLSCR4 interactions | 6.28e-04 | 75 | 45 | 3 | int:PLSCR4 | |
| Interaction | MAML2 interactions | 6.49e-04 | 17 | 45 | 2 | int:MAML2 | |
| Interaction | CRP interactions | 6.78e-04 | 77 | 45 | 3 | int:CRP | |
| Interaction | CCN6 interactions | 8.14e-04 | 19 | 45 | 2 | int:CCN6 | |
| GeneFamily | Laminin subunits | 4.80e-12 | 12 | 28 | 5 | 626 | |
| GeneFamily | Fibronectin type III domain containing | 1.02e-04 | 160 | 28 | 4 | 555 | |
| GeneFamily | Fibrinogen C domain containing | 6.79e-04 | 25 | 28 | 2 | 554 | |
| GeneFamily | Nuclear hormone receptors | 2.60e-03 | 49 | 28 | 2 | 71 | |
| Coexpression | NABA_MATRISOME | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 ADAM33 LAMC2 MEGF6 MEGF8 TNR SSPOP ADAMTSL4 TNXB MEGF11 WNT3A WIF1 | 1.88e-14 | 1008 | 45 | 18 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 LAMC2 TNR SSPOP TNXB | 1.88e-14 | 191 | 45 | 11 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 LAMC2 TNR SSPOP TNXB | 2.51e-14 | 196 | 45 | 11 | M3008 |
| Coexpression | NABA_MATRISOME | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 ADAM33 LAMC2 MEGF6 MEGF8 TNR SSPOP ADAMTSL4 TNXB MEGF11 WNT3A WIF1 | 2.54e-14 | 1026 | 45 | 18 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 LAMC2 TNR SSPOP TNXB | 8.42e-13 | 270 | 45 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | LAMA3 NTNG1 CRELD2 LAMA5 LAMB1 SNED1 LAMB2 LAMC2 TNR SSPOP TNXB | 1.03e-12 | 275 | 45 | 11 | M5884 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 6.65e-11 | 40 | 45 | 6 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 3.90e-10 | 23 | 45 | 5 | M48001 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 3.60e-08 | 20 | 45 | 4 | MM17053 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 2.58e-06 | 704 | 45 | 9 | M45672 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.61e-06 | 16 | 45 | 3 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.61e-06 | 16 | 45 | 3 | MM1296 | |
| Coexpression | KANG_FLUOROURACIL_RESISTANCE_DN | 2.61e-06 | 16 | 45 | 3 | M12110 | |
| Coexpression | SINGH_KRAS_DEPENDENCY_SIGNATURE | 5.28e-06 | 20 | 45 | 3 | M2851 | |
| Coexpression | DESCARTES_FETAL_EYE_HORIZONTAL_CELLS | 7.12e-06 | 22 | 45 | 3 | M40179 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_DN | 2.35e-05 | 200 | 45 | 5 | M4818 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | 2.96e-05 | 955 | 45 | 9 | M45680 | |
| Coexpression | JAEGER_METASTASIS_DN | 8.16e-05 | 260 | 45 | 5 | M10702 | |
| Coexpression | GOZGIT_ESR1_TARGETS_UP | 1.25e-04 | 149 | 45 | 4 | M13944 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 1.40e-04 | 909 | 45 | 8 | M41018 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 1.94e-04 | 313 | 45 | 5 | M40228 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.14e-04 | 505 | 45 | 6 | M39167 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.44e-04 | 738 | 45 | 7 | MM17058 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST | 2.49e-04 | 71 | 45 | 3 | M45664 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.71e-04 | 751 | 45 | 7 | M5885 | |
| Coexpression | NABA_SECRETED_FACTORS | 2.77e-04 | 338 | 45 | 5 | MM17064 | |
| Coexpression | NABA_SECRETED_FACTORS | 2.96e-04 | 343 | 45 | 5 | M5883 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 3.16e-04 | 77 | 45 | 3 | M40001 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 3.41e-04 | 16 | 45 | 2 | M40964 | |
| Coexpression | LEE_LIVER_CANCER_HEPATOBLAST | 3.41e-04 | 16 | 45 | 2 | M13123 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP | 3.69e-04 | 198 | 45 | 4 | M7563 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 4.29e-04 | 206 | 45 | 4 | M14134 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 4.84e-04 | 19 | 45 | 2 | M40932 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN | 4.84e-04 | 19 | 45 | 2 | M40933 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.68e-10 | 183 | 46 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.36e-08 | 172 | 46 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 3.41e-08 | 183 | 46 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-08 | 186 | 46 | 6 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-08 | 191 | 46 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.68e-08 | 193 | 46 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-08 | 199 | 46 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 5.78e-08 | 200 | 46 | 6 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.57e-07 | 173 | 46 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.85e-07 | 174 | 46 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.85e-07 | 174 | 46 | 5 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-06 | 176 | 46 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.13e-06 | 179 | 46 | 5 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-06 | 180 | 46 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-06 | 180 | 46 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.26e-06 | 183 | 46 | 5 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-06 | 187 | 46 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.48e-06 | 189 | 46 | 5 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 189 | 46 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-06 | 192 | 46 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 193 | 46 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 193 | 46 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 193 | 46 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.64e-06 | 193 | 46 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-06 | 194 | 46 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-06 | 194 | 46 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.72e-06 | 195 | 46 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.72e-06 | 195 | 46 | 5 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.77e-06 | 196 | 46 | 5 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-06 | 197 | 46 | 5 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-06 | 197 | 46 | 5 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-06 | 197 | 46 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-06 | 197 | 46 | 5 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-06 | 197 | 46 | 5 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.86e-06 | 198 | 46 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 198 | 46 | 5 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.90e-06 | 199 | 46 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.90e-06 | 199 | 46 | 5 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.90e-06 | 199 | 46 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 199 | 46 | 5 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 199 | 46 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.95e-06 | 200 | 46 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.95e-06 | 200 | 46 | 5 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.95e-06 | 200 | 46 | 5 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-06 | 200 | 46 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-06 | 200 | 46 | 5 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.95e-06 | 200 | 46 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.95e-06 | 200 | 46 | 5 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.95e-06 | 200 | 46 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-06 | 200 | 46 | 5 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.95e-06 | 200 | 46 | 5 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.13e-05 | 158 | 46 | 4 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.46e-05 | 164 | 46 | 4 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 166 | 46 | 4 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 166 | 46 | 4 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 2.97e-05 | 172 | 46 | 4 | 2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.11e-05 | 174 | 46 | 4 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 174 | 46 | 4 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 174 | 46 | 4 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 175 | 46 | 4 | f1166b567bca80dac3abe90c3dc544c831006640 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 175 | 46 | 4 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-05 | 176 | 46 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-05 | 176 | 46 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.25e-05 | 176 | 46 | 4 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-05 | 179 | 46 | 4 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.47e-05 | 179 | 46 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 3.47e-05 | 179 | 46 | 4 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 180 | 46 | 4 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 180 | 46 | 4 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 181 | 46 | 4 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.62e-05 | 181 | 46 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-05 | 182 | 46 | 4 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-05 | 182 | 46 | 4 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.70e-05 | 182 | 46 | 4 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-05 | 182 | 46 | 4 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-05 | 182 | 46 | 4 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 3.78e-05 | 183 | 46 | 4 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.86e-05 | 184 | 46 | 4 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.86e-05 | 184 | 46 | 4 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 185 | 46 | 4 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 185 | 46 | 4 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.95e-05 | 185 | 46 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.95e-05 | 185 | 46 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 185 | 46 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 185 | 46 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 185 | 46 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 185 | 46 | 4 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.03e-05 | 186 | 46 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.03e-05 | 186 | 46 | 4 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 4.03e-05 | 186 | 46 | 4 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.03e-05 | 186 | 46 | 4 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.11e-05 | 187 | 46 | 4 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.11e-05 | 187 | 46 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.11e-05 | 187 | 46 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 187 | 46 | 4 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.11e-05 | 187 | 46 | 4 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.11e-05 | 187 | 46 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.20e-05 | 188 | 46 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.20e-05 | 188 | 46 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 188 | 46 | 4 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| Computational | Adhesion molecules. | 2.57e-06 | 141 | 31 | 6 | MODULE_122 | |
| Computational | Intermediate filaments and MT. | 4.05e-05 | 68 | 31 | 4 | MODULE_438 | |
| Computational | Intermediate filaments. | 5.96e-05 | 75 | 31 | 4 | MODULE_154 | |
| Computational | Genes in the cancer module 297. | 7.68e-05 | 80 | 31 | 4 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 7.68e-05 | 80 | 31 | 4 | MODULE_357 | |
| Computational | DRG (dorsal root ganglia) genes. | 8.79e-05 | 384 | 31 | 7 | MODULE_2 | |
| Computational | Trachea genes. | 1.43e-04 | 415 | 31 | 7 | MODULE_6 | |
| Computational | Placenta genes. | 2.81e-04 | 463 | 31 | 7 | MODULE_38 | |
| Computational | Heart genes. | 1.14e-03 | 423 | 31 | 6 | MODULE_60 | |
| Computational | Lung genes. | 1.30e-03 | 434 | 31 | 6 | MODULE_5 | |
| Computational | Neighborhood of CDH3 | 2.70e-03 | 27 | 31 | 2 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 2.90e-03 | 28 | 31 | 2 | GNF2_SERPINB5 | |
| Computational | Ovary genes. | 3.73e-03 | 368 | 31 | 5 | MODULE_1 | |
| Computational | ECM and collagens. | 3.77e-03 | 225 | 31 | 4 | MODULE_47 | |
| Computational | Genes in the cancer module 153. | 4.26e-03 | 34 | 31 | 2 | MODULE_153 | |
| Drug | AC1L1G72 | 1.10e-11 | 11 | 45 | 5 | CID000003553 | |
| Drug | BM165 | 1.10e-11 | 11 | 45 | 5 | CID003352881 | |
| Drug | kalinin | 1.37e-11 | 55 | 45 | 7 | CID000032518 | |
| Drug | Gdrgdsp | 3.96e-11 | 109 | 45 | 8 | CID000115346 | |
| Drug | ALT-711 | 4.77e-10 | 21 | 45 | 5 | CID000216304 | |
| Drug | Rgd Peptide | 8.49e-10 | 239 | 45 | 9 | CID000104802 | |
| Drug | Sikvav | 9.91e-10 | 24 | 45 | 5 | CID005487517 | |
| Drug | 2,4-diaminopyrimidine | 1.01e-09 | 54 | 45 | 6 | CID000067431 | |
| Drug | AC1L9INI | 1.76e-09 | 59 | 45 | 6 | CID000445839 | |
| Drug | AC1L1B58 | 2.75e-09 | 29 | 45 | 5 | CID000001288 | |
| Drug | 2-amino-5-methylpyridine | 9.00e-09 | 77 | 45 | 6 | CID000015348 | |
| Drug | Calcort | 1.15e-08 | 38 | 45 | 5 | CID000026709 | |
| Drug | Ikvav | 1.15e-08 | 38 | 45 | 5 | CID000131343 | |
| Drug | Grgds | 1.42e-08 | 83 | 45 | 6 | CID000123811 | |
| Drug | NSC 714187 | 1.64e-08 | 85 | 45 | 6 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 1.76e-08 | 86 | 45 | 6 | CID000001322 | |
| Drug | quinaprilat | 2.18e-08 | 43 | 45 | 5 | CID000107994 | |
| Drug | DB04780 | 4.08e-08 | 170 | 45 | 7 | CID005459389 | |
| Drug | B-Ms | 9.59e-08 | 114 | 45 | 6 | CID000445091 | |
| Drug | CC270 | 1.11e-07 | 59 | 45 | 5 | CID006918852 | |
| Drug | LG 5 | 1.21e-07 | 60 | 45 | 5 | CID011840957 | |
| Drug | dermatan sulfate | 2.37e-07 | 220 | 45 | 7 | CID000032756 | |
| Drug | trypanothione disulfide | 3.25e-07 | 140 | 45 | 6 | CID000115098 | |
| Drug | dysprosium | 3.49e-07 | 74 | 45 | 5 | CID000023912 | |
| Drug | A0395 | 3.73e-07 | 75 | 45 | 5 | CID009906466 | |
| Drug | YIGSR | 4.85e-07 | 79 | 45 | 5 | CID000123977 | |
| Drug | I-Q-S | 6.14e-07 | 156 | 45 | 6 | CID000003540 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 6.21e-07 | 83 | 45 | 5 | CID011968896 | |
| Drug | hyaluronan | 7.90e-07 | 263 | 45 | 7 | CID000024759 | |
| Drug | poly-N-acetyllactosamine | 8.32e-07 | 88 | 45 | 5 | CID000119547 | |
| Drug | H-9 dihydrochloride | 9.30e-07 | 90 | 45 | 5 | CID000003544 | |
| Drug | chondroitin sulfate | 1.31e-06 | 413 | 45 | 8 | CID000024766 | |
| Drug | Rgds Peptide | 2.10e-06 | 106 | 45 | 5 | CID000107775 | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.46e-06 | 198 | 45 | 6 | 5984_UP | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 2.46e-06 | 198 | 45 | 6 | 6748_UP | |
| Drug | AC1L1C2F | 2.52e-06 | 110 | 45 | 5 | CID000001711 | |
| Drug | 2-amino-4,6-dinitrotoluene | 1.11e-05 | 70 | 45 | 4 | ctd:C035208 | |
| Drug | AC1O0B8G | 1.23e-05 | 262 | 45 | 6 | CID000091605 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.34e-05 | 155 | 45 | 5 | 6817_DN | |
| Drug | 3-ethylpyridine | 2.29e-05 | 4 | 45 | 2 | CID000010823 | |
| Drug | tranylcypromine | 3.14e-05 | 91 | 45 | 4 | CID000005530 | |
| Drug | LMWH | 4.12e-05 | 663 | 45 | 8 | CID000000772 | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.36e-05 | 198 | 45 | 5 | 4413_UP | |
| Drug | AC1O5SNJ | 5.70e-05 | 6 | 45 | 2 | CID006439900 | |
| Drug | FR 139317 | 7.97e-05 | 7 | 45 | 2 | ctd:C079574 | |
| Drug | cobalt-60 | 1.13e-04 | 390 | 45 | 6 | CID000061492 | |
| Drug | Reidispongiolide C | 2.18e-04 | 279 | 45 | 5 | CID005289285 | |
| Drug | dl-Lysine | 2.61e-04 | 290 | 45 | 5 | CID000000866 | |
| Drug | mono-(2-ethylhexyl)phthalate | 2.85e-04 | 658 | 45 | 7 | ctd:C016599 | |
| Drug | Triton X-100 | 3.03e-04 | 66 | 45 | 3 | CID000005590 | |
| Drug | Roxithromycin | 3.42e-04 | 14 | 45 | 2 | ctd:D015575 | |
| Drug | isocycloheximide | 3.52e-04 | 905 | 45 | 8 | CID000002900 | |
| Drug | quercetin | 3.53e-04 | 482 | 45 | 6 | CID005280343 | |
| Drug | carbachol | 3.73e-04 | 688 | 45 | 7 | CID000002551 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 3.76e-04 | 314 | 45 | 5 | CID000003542 | |
| Drug | Sas 1 | 4.50e-04 | 16 | 45 | 2 | CID006328170 | |
| Drug | Griseofulvin | 4.76e-04 | 77 | 45 | 3 | ctd:D006118 | |
| Drug | zoledronic acid | LAMA3 LRP3 NTNG1 LAMA5 LAMB1 LAMC2 FCGBP TENM4 MEGF11 NOTCH3 | 4.91e-04 | 1472 | 45 | 10 | ctd:C088658 |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 4.95e-04 | 186 | 45 | 4 | 4271_UP | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 5.15e-04 | 188 | 45 | 4 | 2239_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 5.57e-04 | 192 | 45 | 4 | 4175_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 5998_UP | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 4306_UP | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 4503_UP | |
| Drug | Scopoletin [92-61-5]; Up 200; 20.8uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 45 | 4 | 6510_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 45 | 4 | 5914_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 5.79e-04 | 194 | 45 | 4 | 1267_UP | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 5.79e-04 | 194 | 45 | 4 | 2114_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A | 5.79e-04 | 194 | 45 | 4 | 4301_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HG-U133A | 5.91e-04 | 195 | 45 | 4 | 489_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 6330_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.91e-04 | 195 | 45 | 4 | 983_UP | |
| Drug | 17-AAG; Down 200; 1uM; SKMEL5; HG-U133A | 5.91e-04 | 195 | 45 | 4 | 505_DN | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 3542_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 3789_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6315_DN | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3042_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 4119_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3633_DN | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6601_UP | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3372_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; HL60; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 2547_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3923_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 4307_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3732_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6027_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6715_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 2236_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A | 6.02e-04 | 196 | 45 | 4 | 203_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6060_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 7011_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 4207_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 6890_UP | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 5340_DN | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 6320_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 5564_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 3382_UP | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; HL60; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 2149_DN | |
| Drug | indomethacin, USP; Down 200; 100uM; SKMEL5; HG-U133A | 6.14e-04 | 197 | 45 | 4 | 503_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 6400_UP | |
| Disease | Epidermolysis Bullosa Progressiva | 1.15e-08 | 4 | 43 | 3 | C0079297 | |
| Disease | Herlitz Disease | 1.15e-08 | 4 | 43 | 3 | C0079683 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 2.88e-08 | 5 | 43 | 3 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 2.88e-08 | 5 | 43 | 3 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 2.88e-08 | 5 | 43 | 3 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 5.75e-08 | 6 | 43 | 3 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.00e-07 | 7 | 43 | 3 | DOID:3209 (is_implicated_in) | |
| Disease | Junctional epidermolysis bullosa | 6.22e-06 | 3 | 43 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 6.22e-06 | 3 | 43 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 6.22e-06 | 3 | 43 | 2 | 226700 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 9.27e-05 | 10 | 43 | 2 | EFO_0022035 | |
| Disease | Amelogenesis Imperfecta | 1.36e-04 | 12 | 43 | 2 | C0002452 | |
| Disease | Manic Disorder | 1.54e-04 | 71 | 43 | 3 | C0024713 | |
| Disease | Manic | 2.03e-04 | 78 | 43 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 2.11e-04 | 79 | 43 | 3 | C0005587 | |
| Disease | caffeine measurement | 2.15e-04 | 15 | 43 | 2 | EFO_0021177 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 2.46e-04 | 16 | 43 | 2 | EFO_0020346 | |
| Disease | Astrocytosis | 2.78e-04 | 17 | 43 | 2 | C3887640 | |
| Disease | Gliosis | 2.78e-04 | 17 | 43 | 2 | C0017639 | |
| Disease | X-11470 measurement | 3.49e-04 | 19 | 43 | 2 | EFO_0021241 | |
| Disease | Carcinoma, Pancreatic Ductal | 5.61e-04 | 24 | 43 | 2 | C0887833 | |
| Disease | complement C4b measurement | 6.09e-04 | 25 | 43 | 2 | EFO_0008092 | |
| Disease | myeloperoxidase measurement | 6.59e-04 | 26 | 43 | 2 | EFO_0005243 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 7.65e-04 | 28 | 43 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | response to angiotensin receptor blocker | 8.79e-04 | 30 | 43 | 2 | EFO_0010735 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDGCGVCGGDDSTCR | 471 | Q6UY14 | |
| GGAASAQDGRCPCGA | 66 | O75638 | |
| GGAASGLNGCCRCGA | 66 | P78358 | |
| GLNGCCRCGARGPES | 71 | P78358 | |
| DPSGCCVGNDCRDGG | 26 | Q6ZRV3 | |
| GQEAGGRPGADCEVC | 26 | Q49AH0 | |
| EAGEECDCGPGQECR | 426 | Q9BZ11 | |
| GPEDCADPSGCVCGN | 201 | Q9BXJ7 | |
| GPCDGNPCANGGSCS | 276 | Q9NYJ7 | |
| CADGPCFNGGLCVGG | 316 | Q9NYJ7 | |
| GGSEGRCAVCGDNAS | 261 | P22736 | |
| CENGGSCSPEDGSCE | 581 | A6BM72 | |
| SCDLGGRDLCGGCTG | 696 | Q96RG2 | |
| GTGECRQGDGDCHCK | 641 | Q16787 | |
| ADGDGGGGQCCRRQD | 721 | Q9Y5F6 | |
| CDRECNSPGCGWDGG | 1401 | Q9UM47 | |
| GVCACEPGWGGPDCG | 156 | Q7Z7M0 | |
| GLQDCGDGSDEAGCP | 236 | O75074 | |
| GDGSDEAGCPDLACG | 241 | O75074 | |
| CRTDEGERKCGGPGC | 1416 | P07942 | |
| SPCGGAGCRDEDGQP | 1421 | P55268 | |
| GCRPCACGPAAEGSE | 2066 | O15230 | |
| EGEDKPCSGRGECQC | 506 | P16144 | |
| DQCWGCSCGDEPGVG | 36 | P51843 | |
| GGGRCCPEQEEGESA | 6 | Q9UBB5 | |
| DGTCSQWCRCGPGGG | 3226 | Q9Y6R7 | |
| RCECGPGGHVTCQEG | 4816 | Q9Y6R7 | |
| CNPDGAELCSPCGGG | 81 | Q9H665 | |
| CDRGSGQQGGGSGCC | 71 | Q5T5B0 | |
| CNCQGGGACDPDTGD | 416 | Q13753 | |
| CTGEGPGNCKECISG | 266 | Q6UXH1 | |
| GEGENRGCCGSLCQA | 481 | Q01668 | |
| GTCLLGLDGCDCPEG | 531 | O75095 | |
| FGEGCHQRCDCDGGA | 1426 | O75095 | |
| HCDCGGGADCDPVSG | 1476 | O75095 | |
| RCEEAGSCGSDSGQG | 501 | Q9Y2I2 | |
| CADGSDERGCGGPCA | 1591 | A2VEC9 | |
| ETDGCPDLCNGNGRC | 806 | Q9NT68 | |
| GCNTAECGWDGGDCR | 1271 | Q99466 | |
| RDDIGCGAPGCAACG | 26 | Q9Y2L1 | |
| GGRCESGGGAYLCVC | 841 | Q8TER0 | |
| GGSGAGRSSCDCPNC | 261 | Q8TDD2 | |
| GGRCVCDPGYTGDDC | 261 | P22105 | |
| DCGTRSCPWDCGEGG | 336 | P22105 | |
| SCPWDCGEGGRCVDG | 341 | P22105 | |
| GDDCGVRSCPGDCNQ | 396 | P22105 | |
| GEDCSTRSCPGGCRG | 551 | P22105 | |
| CPGDCSGKGRCANGT | 266 | Q92752 | |
| GVDSCSGDAGGPLAC | 1001 | Q7Z410 | |
| ADCGGHGVCVGGTCR | 731 | Q6N022 | |
| CNQGPLGDGSCDCDV | 1406 | Q8WWQ8 | |
| TCQQAECPGGCRNGG | 176 | Q9Y5W5 | |
| ECPGGCRNGGFCNER | 181 | Q9Y5W5 | |
| APERGGGSCVLCCGD | 21 | Q86UK7 | |
| SHGIDGCDLLCCGRG | 301 | P56704 | |
| AAVRAGGKGCCGAGC | 66 | O14894 | |
| AGDPGCQTCAACGPG | 96 | Q04912 |